Dr. Susan Girois hosted the conversation discussing several topics relating to vaccines, including how they are developed and tested.

Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults ...

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

The Trump administration said it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending ...

To understand the mechanism of the nasal vaccines, the researchers first injected mice with a traditional mRNA COVID-19 shot, ...

The World Health Organization's member countries have approved an agreement to better prevent, prepare for and respond to ...

The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...

The Food and Drug Administration has outlined new regulations for COVID-19 booster shots, setting stricter approval standards ...